Project Number 1R41AG055224-01A1 Agency/Funding Organization NIA Funding Year 2018 View Full Project Details for Optimization of Novel Ryanodine Receptor Modulatory Compounds for Alzheimers Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) m. Synaptic Plasticity/Neuroprotection Researcher and Organization Principal Investigator STUTZMANN, GRACE Principal Investigator First Name GRACE Principal Investigator Last Name STUTZMANN Awardee Organization NEUROLUCENT, INC. Awardee State Illinios Contact PI Country United States Project Detail Funding Opportunity Announcement PA-17-303: PHS 2017-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42]) FY Overall Cost $225,000 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official REFOLO, LORENZO
